FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2508206883> ?p ?o ?g. }

• W2508206883 abstract "Abstract ETV6/RUNX1 rearrangement, being the most common genetic abnormality in childhood ALL, is combined with controversial prognostic behavior and frequent late relapses, indicating the need for identification of additional prognostic markers. In our study, we examined the relation between ETV6/RUNX1 and presenting clinical/biological features, co-existing subclones/secondary aberrations, early response to treatment (MRD) and their impact on outcome in a pediatric cohort of 133 ALL pts , treated in one Center over a 12-year period. Data from 133 newly diagnosed ALL pts(83 males) with a median age of 5.1 yrs(range 1.2-16.7), have been retrospectively recorded and analyzed. Pts were consecutively diagnosed and homogeneously treated on BFM based protocols during the years 2000-2011. FISH evaluation using commercial probe sets was performed for the detection of ETV6-RUNX1, E2A-PBX1, BCR-ABL fusion genes, MLL gene rearrangements as well as ETV6, RUNX1, CDKN2A/2B and other gene duplications, deletions or amplifications. Twenty seven pts (27/133, 20.3%) were tested positive for the t(12;21)(p13;q22) translocation(16 males), with a median age of 3.9 yrs(range 2.0-16.7). Immunophenotype revealed 22/27 common (81.5%) and 5/32 pre-B cases (18.5%). All pts were characterized as GPR and treated in the IR Arm. 8/27 (29.6%) were positive for the ETV6/RUNX1 fusion gene only with no secondary aberrations. 19/27 ETV6/RUNX1-positive pts (70.4%) harbored additional structural or numerical genetic abnormalities while 8 of those pts showed presence of subclones with multiple patterns of additional ETV6 and RUNX1 aberrations. The most common abnormalities were del12p13(37%), 3-6x21q22(22.2%), del9p21(18.5%), +21(14.8%), and 2-3xETV6/RUNX1(18.5%). On day 15, 13/27 ETV6/RUNX1+ pts (48.1%) presented with FCM-MRD(d15) values≥10-3 while the corresponding percent among IR ETV6/RUNX1- pts was 46.9%. Out the 8 pts with sole t(12;21)(p13;q22) translocation, only 25%(2/8 pts) presented with MRD(d15)>10-3 while among the 19 pts with additional aberrations, the corresponding percent was 52.6% (10/19). Interestingly, referring only to ETV6/RUXN1+ pts with subclones, the percent reflecting MRD(d15)>0.1% rises to 87.5% (7/8 pts). Among the 14 pts with no MRD(d15) detection only 1/14 appeared with clonal heterogeneity. 3/27 pts (11.1%) relapsed, in a median time of 30.3 months (median follow-up time 64 months). Common features of all relapses were sub-clonal diversity at diagnosis, del(9p21) and MRD(d15) positivity. 5-year RFS for the ETV6/RUNX1+ subgroup was 86.4%±7.4 vs 87.7%±3.5 for ETV6/RUNX1- pts. The presence of the ETV6/RUNX1 fusion gene as a favorable genetic marker did not seem to have a statistically significant impact on the probability of relapse (p=0.906). The 5-year RFS for those with MRD≥0.1% was limited to 67.3% ±16.0, while the corresponding rate for MRD- pts reached 100%. ETV6/RUNX1+ childhood ALL is characterized by extreme heterogeneity and the prognostic value of the fusion itself varies, depending on coexisting clinical and biological features. In our series, the presence of additional genetic aberrations/subclones (such as del9p21 or ETV6/RUNX1 duplication) and impaired FCM-MRD clearance, influences patient outcome. Longer follow-up is needed in order to further validate these initial results. FISH and FCM data may help establish new prognostic markers to predict relapse and refine risk stratification. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare." @default.
• W2508206883 created "2016-09-16" @default.
• W2508206883 creator A5003595036 @default.
• W2508206883 creator A5007777254 @default.
• W2508206883 creator A5036906548 @default.
• W2508206883 creator A5046421930 @default.
• W2508206883 creator A5046487117 @default.
• W2508206883 creator A5051384960 @default.
• W2508206883 creator A5062445900 @default.
• W2508206883 creator A5064862590 @default.
• W2508206883 creator A5075968682 @default.
• W2508206883 date "2014-12-06" @default.
• W2508206883 modified "2023-09-28" @default.
• W2508206883 title "ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?" @default.
• W2508206883 doi "https://doi.org/10.1182/blood.v124.21.2403.2403" @default.
• W2508206883 hasPublicationYear "2014" @default.
• W2508206883 type Work @default.
• W2508206883 sameAs 2508206883 @default.
• W2508206883 citedByCount "0" @default.
• W2508206883 crossrefType "journal-article" @default.
• W2508206883 hasAuthorship W2508206883A5003595036 @default.
• W2508206883 hasAuthorship W2508206883A5007777254 @default.
• W2508206883 hasAuthorship W2508206883A5036906548 @default.
• W2508206883 hasAuthorship W2508206883A5046421930 @default.
• W2508206883 hasAuthorship W2508206883A5046487117 @default.
• W2508206883 hasAuthorship W2508206883A5051384960 @default.
• W2508206883 hasAuthorship W2508206883A5062445900 @default.
• W2508206883 hasAuthorship W2508206883A5064862590 @default.
• W2508206883 hasAuthorship W2508206883A5075968682 @default.
• W2508206883 hasConcept C104317684 @default.
• W2508206883 hasConcept C111829193 @default.
• W2508206883 hasConcept C121608353 @default.
• W2508206883 hasConcept C126322002 @default.
• W2508206883 hasConcept C138626823 @default.
• W2508206883 hasConcept C143998085 @default.
• W2508206883 hasConcept C147483822 @default.
• W2508206883 hasConcept C187212893 @default.
• W2508206883 hasConcept C196166836 @default.
• W2508206883 hasConcept C203014093 @default.
• W2508206883 hasConcept C2780265364 @default.
• W2508206883 hasConcept C2780833115 @default.
• W2508206883 hasConcept C54355233 @default.
• W2508206883 hasConcept C71924100 @default.
• W2508206883 hasConcept C72563966 @default.
• W2508206883 hasConcept C86803240 @default.
• W2508206883 hasConcept C90924648 @default.
• W2508206883 hasConceptScore W2508206883C104317684 @default.
• W2508206883 hasConceptScore W2508206883C111829193 @default.
• W2508206883 hasConceptScore W2508206883C121608353 @default.
• W2508206883 hasConceptScore W2508206883C126322002 @default.
• W2508206883 hasConceptScore W2508206883C138626823 @default.
• W2508206883 hasConceptScore W2508206883C143998085 @default.
• W2508206883 hasConceptScore W2508206883C147483822 @default.
• W2508206883 hasConceptScore W2508206883C187212893 @default.
• W2508206883 hasConceptScore W2508206883C196166836 @default.
• W2508206883 hasConceptScore W2508206883C203014093 @default.
• W2508206883 hasConceptScore W2508206883C2780265364 @default.
• W2508206883 hasConceptScore W2508206883C2780833115 @default.
• W2508206883 hasConceptScore W2508206883C54355233 @default.
• W2508206883 hasConceptScore W2508206883C71924100 @default.
• W2508206883 hasConceptScore W2508206883C72563966 @default.
• W2508206883 hasConceptScore W2508206883C86803240 @default.
• W2508206883 hasConceptScore W2508206883C90924648 @default.
• W2508206883 hasLocation W25082068831 @default.
• W2508206883 hasOpenAccess W2508206883 @default.
• W2508206883 hasPrimaryLocation W25082068831 @default.
• W2508206883 hasRelatedWork W1742893751 @default.
• W2508206883 hasRelatedWork W2487013105 @default.
• W2508206883 hasRelatedWork W2502293864 @default.
• W2508206883 hasRelatedWork W2530676559 @default.
• W2508206883 hasRelatedWork W2536785348 @default.
• W2508206883 hasRelatedWork W2553498421 @default.
• W2508206883 hasRelatedWork W2554514211 @default.
• W2508206883 hasRelatedWork W2557606292 @default.
• W2508206883 hasRelatedWork W2558860354 @default.
• W2508206883 hasRelatedWork W2574395896 @default.
• W2508206883 hasRelatedWork W2575989606 @default.
• W2508206883 hasRelatedWork W2577089027 @default.
• W2508206883 hasRelatedWork W2601041228 @default.
• W2508206883 hasRelatedWork W2795052459 @default.
• W2508206883 hasRelatedWork W2979483636 @default.
• W2508206883 hasRelatedWork W2979611839 @default.
• W2508206883 hasRelatedWork W2980057690 @default.
• W2508206883 hasRelatedWork W3117686136 @default.
• W2508206883 hasRelatedWork W3133865522 @default.
• W2508206883 hasRelatedWork W2531917124 @default.
• W2508206883 isParatext "false" @default.
• W2508206883 isRetracted "false" @default.
• W2508206883 magId "2508206883" @default.
• W2508206883 workType "article" @default.